Detalles de la búsqueda
1.
Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.
Hematol Oncol
; 40(4): 667-677, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35142384
2.
Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial.
Jpn J Clin Oncol
; 52(6): 583-588, 2022 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35353186
3.
Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1).
Jpn J Clin Oncol
; 51(7): 1059-1066, 2021 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33959770
4.
[A rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma with multiple solitary extramedullary plasmacytomas of the liver].
Rinsho Ketsueki
; 62(7): 727-732, 2021.
Artículo
en Japonés
| MEDLINE | ID: mdl-34349055
5.
R-CHOP-14 versus R-CHOP-14/CHASER for upfront autologous transplantation in diffuse large B-cell lymphoma: JCOG0908 study.
Cancer Sci
; 111(10): 3770-3779, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32767806
6.
Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant-ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105.
Hematol Oncol
; 41(3): 590-593, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36416678
7.
Immune thrombocytopenia induced by vonoprazan fumarate: a single center retrospective study.
Ann Hematol
; 97(4): 741-742, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29247400
8.
Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab.
Ann Hematol
; 97(11): 2253-2255, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29725760
9.
Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling.
J Pathol
; 223(4): 496-510, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21294123
10.
Prognostic Impact of a Body Mass Index Decrease during First Chemotherapy in Patients with Advanced Follicular Lymphoma.
Intern Med
; 61(14): 2111-2116, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35850985
11.
A multicenter, phase II study of full-dose THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, aggressive non-Hodgkin lymphoma.
J Clin Exp Hematop
; 62(4): 202-207, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36575000
12.
A case of MYH9 disorders caused by a novel mutation (p.K74E).
Ann Hematol
; 95(1): 161-163, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26382273
13.
Establishment of an ATLL cell line (YG-PLL) dependent on IL-2 and IL-4, which are replaced by OX40-ligand+ HK with poly-L-histidine and dermatan sulfate.
J Clin Exp Hematop
; 61(3): 145-151, 2021 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34334531
14.
A multicenter, phase II study of R-THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, indolent B-cell lymphoma.
J Clin Exp Hematop
; 61(3): 162-167, 2021 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34193755
15.
Development of novel humanized anti-CD20 antibodies based on affinity constant and epitope.
Cancer Sci
; 101(1): 201-9, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19930155
16.
Primary gastric diffuse large B-cell Lymphoma (DLBCL): analyses of prognostic factors and value of pretreatment FDG-PET scan.
Eur J Haematol
; 84(6): 493-8, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20148943
17.
Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.
Cancer Sci
; 99(1): 179-84, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17991293
18.
Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma.
Cancer Sci
; 99(1): 140-4, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17970782
19.
De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.
Haematologica
; 93(8): 1195-202, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18556402
20.
Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab.
Eur J Haematol
; 81(6): 448-53, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18691256